Developing a vaccine for type 1 diabetes by targeting coxsackievirus B
Introduction: Virus infections have long been considered as a possible cause of type 1 diabetes (T1D). One virus group, enteroviruses (EVs), has been studied extensively, and clinical development of a vaccine against T1D-associated EV types has started. Areas covered: Epidemiological studies have in...
Saved in:
Main Authors: | Heikki Hyöty (Author), Francisco Leon (Author), Mikael Knip (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hand, foot, and mouth disease in adults caused by Coxsackievirus B1-B6
by: Anama Di Prinzio, et al.
Published: (2022) -
Treatment Trends of Myocarditis with Coxsackievirus B3 infection
by: Dalya Basil Hanna, et al.
Published: (2020) -
Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province, China
by: Fan Gao, et al.
Published: (2018) -
Combination of dasabuvir and PSI-6206 for the treatment of coxsackievirus B3 infection
by: Oluwatayo Israel Olasunkanmi, et al.
Published: (2022) -
The antiviral effect of jiadifenoic acids C against coxsackievirus B3
by: Miao Ge, et al.
Published: (2014)